TP53 and breast cancer: However, in BC cells, particularly in basal-like and HER2-enriched subtypes, P53 gene mutations induce increased glycolytic activity.109, 110, 111 Basal-like BC cells, in particular, exhibit significantly elevated c-Myc expression, which contributes to the activation of the aerobic glycolysis pathway.112